Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 9.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 12,141 shares of the company’s stock after selling 1,200 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Prestige Consumer Healthcare were worth $836,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also made changes to their positions in PBH. Opal Wealth Advisors LLC purchased a new stake in Prestige Consumer Healthcare in the 2nd quarter valued at $26,000. Principal Securities Inc. purchased a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $29,000. EverSource Wealth Advisors LLC raised its stake in shares of Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after acquiring an additional 208 shares in the last quarter. Gladius Capital Management LP acquired a new stake in Prestige Consumer Healthcare in the 2nd quarter valued at about $35,000. Finally, ORG Partners LLC purchased a new position in Prestige Consumer Healthcare in the second quarter worth approximately $39,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

NYSE:PBH opened at $72.11 on Wednesday. The firm has a market cap of $3.57 billion, a price-to-earnings ratio of 17.29, a price-to-earnings-growth ratio of 2.10 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 12-month low of $56.34 and a 12-month high of $75.80. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The company’s 50-day moving average is $70.46 and its two-hundred day moving average is $69.49.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.06 earnings per share. Research analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Analysts Set New Price Targets

PBH has been the subject of a number of research analyst reports. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. DA Davidson increased their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Finally, StockNews.com downgraded Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $98.75.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.